Target intelligence / Profile preview

ZNF8-ERVK3-1 readthrough (ZNF8-ERVK3-1)

Target
ZNF8-ERVK3-1
Molecular classification
Long non-coding RNA (lncRNA), Readthrough transcript
01

Overview

ZNF8-ERVK3-1 readthrough is a **naturally occurring readthrough transcript** between the neighboring ZNF8 (zinc finger protein 8) and ERVK3-1 (endogenous retrovirus group K3, member 1) genes on human chromosome 19[1][2][6]. This **long non-coding RNA (lncRNA)** is classified as a **candidate for nonsense-mediated mRNA decay** (NMD), meaning it is not believed to produce a stable protein product[1][6]. No protein coding function, receptor activity, or other typical therapeutic target attributes have been described for this transcript, and it has **no established role in disease, drug interaction, or clinical biomarkers**[1][2][6]. Its classification as a readthrough transcript and lncRNA, rather than a protein, receptor, or enzyme, means it is **not considered a bona fide molecular drug target**. This entry may be only of relevance for bioinformatics annotation, not for therapeutic or biomarker purposes, and is therefore considered **not a true target** in the conventional sense[1][2][6].

Other names
ZNF8-ERVK3-1ZNF8-ERVK3-1 readthroughGC19U902302 (various older IDs)
02

Biological functions

None established (lncRNA; candidate for nonsense-mediated mRNA decay)
03

Disease associations

None established

Beyond the preview

Go deeper on ZNF8-ERVK3-1 readthrough (ZNF8-ERVK3-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF8-ERVK3-1 readthrough (ZNF8-ERVK3-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call